More research is on the way and results will be presented. I love speculation and altering viewpoints on RAC, but as the days and weeks, even years follow we will all see what happens. I think the significant upside to this investment is far outweighing the downside. When you look at the data closely and comparatively with other similar drugs, buy-outs or partnerships, this is one not to be missed.
MST valuation of RAC, page-172
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
